Relaxin-3/RXFP3 networks: an emerging target for the treatment of depression and other neuropsychiatric diseases?

• Ngā kaituhi matua: Craig M Smith (Author), Andrew W Walker (Author), Ihaia T Hosken (Author), Berenice E Chua (Author), Cary eZhang (Author), Mouna eHaidar (Author), Andrew L Gundlach (Author)
• Hōputu: Pukapuka
• I whakaputaina: Frontiers Media S.A., 2014-03-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Animal and clinical studies of gene-environment interactions have helped elucidate the mechanisms involved in the pathophysiology of several mental illnesses including anxiety, depression and schizophrenia; and have led to the discovery of improved treatments. The study of neuropeptides and their re...